抑制剂溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 产品编号 | 图片 | 产品描述 | 分子式 | 加入购物车 | |
|---|---|---|---|---|---|
|
Mavacoxib，98% | C16H11F4N3O2S | |||
|
|
|||||
|
MD2-TLR4-IN-1，98% | C22H14Cl2N4O | |||
|
|
|||||
|
|
CAY 10465，98% | C15H9Cl2F3 | |||
|
|
|||||
|
PDM-11，98% | C16H15ClO2 | |||
|
|
|||||
|
NSC247030，98% | C15H9Cl2NO | |||
|
|
|||||
|
TD 139，98% | C28H30F2N6O8S | |||
|
|
|||||
|
Avacopan，98% | C33H35F4N3O2 | |||
|
|
|||||
|
|
GSK-2894631A，98% | C20H24F2N2O3 | |||
|
|
|||||
|
|
RK-33，98% | C23H20N6O3 | |||
|
|
|||||
|
Lumiracoxib，≥98% | C15H13ClFNO2 | |||
|
|
|||||
